Simulation of the international normalized ratio during switching therapy from rivaroxaban to warfarin and its potential clinical implications

被引：0

作者：

Siegmund, H. U. ^{[1
]}

Burghaus, R. ^{[2
]}

Kubitza, D. ^{[2
]}

Coboeken, K. ^{[2
]}

机构：

[1] Bayer Technol Serv GmbH, Leverkusen, Germany

[2] Bayer Pharma AG, Wuppertal, Germany

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：820 / 820

页数：1

共 50 条

[1] Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies
Siegmund, Hans-Ulrich
Burghaus, Rolf
Kubitza, Dagmar
Coboeken, Katrin
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (06) : 959 - 966
[2] Effect of stress on international normalized ratio during warfarin therapy
Hawk, TL
Havrda, DE
[J]. ANNALS OF PHARMACOTHERAPY, 2002, 36 (04) : 617 - 620
[3] MONITORING WARFARIN THERAPY WITH THE INTERNATIONAL NORMALIZED RATIO
HOWARD, PA
[J]. ANNALS OF PHARMACOTHERAPY, 1994, 28 (02) : 242 - 244
[4] Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy
Kuo, A. M.
Brown, J. N.
Clinard, V.
[J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (05) : 505 - 509
[5] Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy
Vadher, B
Patterson, DLH
Leaning, M
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (01) : 63 - 70
[6] Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio?
Merli, Geno J.
Tzanis, George
[J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 27 (03) : 293 - 299
[7] Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio?
Geno J. Merli
George Tzanis
[J]. Journal of Thrombosis and Thrombolysis, 2009, 27 : 293 - 299
[8] International normalized ratio fluctuation with warfarin-fluorouracil therapy
Carabino, J
Wang, F
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (09) : 875 - 875
[9] MONITORING SODIUM WARFARIN THERAPY USING THE INTERNATIONAL NORMALIZED RATIO
WHITE, RH
[J]. WESTERN JOURNAL OF MEDICINE, 1989, 151 (05): : 544 - 544
[10] Inter-Individual Differences in Baseline Coagulation Activities and Their Implications for International Normalized Ratio Control During Warfarin Initiation Therapy
Yosuke Ichimura
Harumi Takahashi
Michael T. M. Lee
Mari Shiomi
Kiyoshi Mihara
Takashi Morita
Yuan-Tsong Chen
Hirotoshi Echizen
[J]. Clinical Pharmacokinetics, 2012, 51 : 799 - 808

← 1 2 3 4 5 →